2 Oct 2026, 10:47
Securities Administration—
TTXTETRATHERIX LIMITED
Announcement history available from 1 August 2025
Fromto
16 Sept 2026, 08:33
Company Update—
31 Aug 2026, 08:28
Company Update—
24 Aug 2026, 11:51
Securities Administration—
20 Aug 2026, 13:07
Financial Results—
20 Aug 2026, 09:05
Financial ResultsMS
22 July 2026, 08:24
Quarterly ReportsMS
1 July 2026, 13:53
Securities Administration—
23 June 2026, 09:53
Company Update—
23 June 2026, 08:15
Securities Administration—
22 June 2026, 08:17
Capital Raising—
19 June 2026, 08:19
Securities Administration—
9 June 2026, 10:46
Securities Administration—
9 June 2026, 08:33
Company Update—
4 June 2026, 09:16
Capital Raising—
4 June 2026, 09:10
Securities Administration—
3 June 2026, 08:20
Securities Administration—
28 May 2026, 09:23
Securities Administration—
28 May 2026, 09:22
Capital RaisingMS
26 May 2026, 09:29
Trading Halt / SuspensionMS
23 Apr 2026, 09:26
Quarterly ReportsMS
1 Apr 2026, 08:20
Securities Administration—
17 Mar 2026, 08:30
Presentations—
16 Mar 2026, 08:17
Company UpdateMS
10 Mar 2026, 09:21
Company UpdateMS
24 Feb 2026, 11:08
Financial Results—
24 Feb 2026, 10:27
Financial ResultsMS
17 Feb 2026, 08:15
Company UpdateMS
28 Jan 2026, 08:21
Quarterly ReportsMS
21 Jan 2026, 11:51
Director Interests—
21 Jan 2026, 11:47
Company Administration—
19 Jan 2026, 08:28
Company UpdateMS
13 Jan 2026, 08:25
Company UpdateMS
9 Jan 2026, 08:19
Securities Administration—
5 Jan 2026, 20:00
Securities Administration—
22 Dec 2025, 09:04
Director Interests—
18 Dec 2025, 17:18
Securities Administration—
18 Dec 2025, 11:42
Director Interests—
16 Dec 2025, 08:21
Company Administration—
8 Dec 2025, 16:46
Securities Administration—
1 Dec 2025, 08:29
Company Update—
20 Nov 2025, 11:48
Securities Administration—
10 Nov 2025, 15:12
Meetings & Governance—
10 Nov 2025, 09:27
Letters & Addresses—
27 Oct 2025, 08:31
Quarterly ReportsMS
14 Oct 2025, 08:42
Company Update—
9 Oct 2025, 16:24
Meetings & Governance—
8 Sept 2025, 15:24
Securities Administration—
5 Sept 2025, 13:43
Securities Administration—
29 Aug 2025, 12:30
Securities Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 2 Oct 2026, 10:47 | Notification regarding unquoted securities - TTX | Securities Administration | — | 06021 | |
| 16 Sept 2026, 08:33 | Line of sight ophthalmic tissue spacing US revenue | Company Update | — | 11001 | |
| 31 Aug 2026, 08:28 | Tetratherix Ships First US Polymer, Revenue Begins | Company Update | — | 11001 | |
| 24 Aug 2026, 11:51 | Application for quotation of securities - TTX | Securities Administration | — | 06020 | |
| 20 Aug 2026, 13:07 | Results Presentation 2026 | Financial Results | — | 03003, 03026 | |
| 20 Aug 2026, 09:05 | Appendix 4E and Annual Report 2026 | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 22 July 2026, 08:24 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 1 July 2026, 13:53 | Notification regarding unquoted securities - TTX | Securities Administration | — | 06021 | |
| 23 June 2026, 09:53 | Tutela Interim Study Results | Company Update | — | 11001 | |
| 23 June 2026, 08:15 | Application for quotation of securities - TTX | Securities Administration | — | 06020 | |
| 22 June 2026, 08:17 | SPP Results | Capital Raising | — | 06017 | |
| 19 June 2026, 08:19 | Application for quotation of securities - TTX | Securities Administration | — | 06020 | |
| 9 June 2026, 10:46 | Mandatory Escrow Release | Securities Administration | — | 06009 | |
| 9 June 2026, 08:33 | Study Results Peptide-Polymer Patents | Company Update | — | 11001 | |
| 4 June 2026, 09:16 | SPP Booklet | Capital Raising | — | 06017 | |
| 4 June 2026, 09:10 | Placement Cleansing Notice | Securities Administration | — | 06018 | |
| 3 June 2026, 08:20 | Application for quotation of securities - TTX | Securities Administration | — | 06020 | |
| 28 May 2026, 09:23 | Proposed issue of securities - TTX | Securities Administration | — | 06013 | |
| 28 May 2026, 09:22 | Successful Completion $15M Placement | Capital Raising | MS | 03026, 06003, 06017, 09014 | |
| 26 May 2026, 09:29 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 23 Apr 2026, 09:26 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 1 Apr 2026, 08:20 | Notification regarding unquoted securities - TTX | Securities Administration | — | 06021 | |
| 17 Mar 2026, 08:30 | Tetratherix March Investor Presentation | Presentations | — | 03026 | |
| 16 Mar 2026, 08:17 | Precision medicine franchise launch and new revenue | Company Update | MS | 11001 | |
| 10 Mar 2026, 09:21 | Tutelix Update | Company Update | MS | 11001 | |
| 24 Feb 2026, 11:08 | HY FY26 Letter | Financial Results | — | 03004, 03014 | |
| 24 Feb 2026, 10:27 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 17 Feb 2026, 08:15 | TetraDerm Cohort 1 Results | Company Update | MS | 11001 | |
| 28 Jan 2026, 08:21 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 21 Jan 2026, 11:51 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 21 Jan 2026, 11:47 | Vecchione Appointment | Company Administration | — | 12001 | |
| 19 Jan 2026, 08:28 | Executed Henry Schein Agreement | Company Update | MS | 11001 | |
| 13 Jan 2026, 08:25 | TetraDerm Cohort 2 | Company Update | MS | 11001 | |
| 9 Jan 2026, 08:19 | Application for quotation of securities - TTX | Securities Administration | — | 06020 | |
| 5 Jan 2026, 20:00 | Notification regarding unquoted securities - TTX | Securities Administration | — | 06021 | |
| 22 Dec 2025, 09:04 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 18 Dec 2025, 17:18 | Application for quotation of securities - TTX | Securities Administration | — | 06020 | |
| 18 Dec 2025, 11:42 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 16 Dec 2025, 08:21 | Director Company Secretary Appointment/Resignation | Company Administration | — | 12001, 12007 | |
| 8 Dec 2025, 16:46 | Application for quotation of securities - TTX | Securities Administration | — | 06020 | |
| 1 Dec 2025, 08:29 | BioOptix Alcon Update | Company Update | — | 11001 | |
| 20 Nov 2025, 11:48 | Notice of Escrow Release | Securities Administration | — | 06009 | |
| 10 Nov 2025, 15:12 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 10 Nov 2025, 09:27 | 2025 AGM Chair and CEO Address | Letters & Addresses | — | 15002 | |
| 27 Oct 2025, 08:31 | Q1FY26 Quarterly Activities Report/Appendix 4C | Quarterly Reports | MS | 19001, 19006 | |
| 14 Oct 2025, 08:42 | Tutela Update | Company Update | — | 11001 | |
| 9 Oct 2025, 16:24 | 2025 Notice of Annual General Meeting | Meetings & Governance | — | 08001, 08004 | |
| 8 Sept 2025, 15:24 | Application for quotation of securities - TTX | Securities Administration | — | 06020 | |
| 5 Sept 2025, 13:43 | Application for quotation of securities - TTX | Securities Administration | — | 06020 | |
| 29 Aug 2025, 12:30 | Notice of Escrow Release | Securities Administration | — | 06009 |
1–50 of 57
1 / 2